142 related articles for article (PubMed ID: 37460404)
1. Drug Repurposing-Based Brain-Targeting Self-Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma.
Liang J; Li L; Tian H; Wang Z; Liu G; Duan X; Guo M; Liu J; Zhang W; Nice EC; Huang C; He W; Zhang H; Li Q
Small; 2023 Nov; 19(46):e2303073. PubMed ID: 37460404
[TBL] [Abstract][Full Text] [Related]
2. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
[TBL] [Abstract][Full Text] [Related]
3. A Brain-Targeting NIR-II Ferroptosis System: Effective Visualization and Oncotherapy for Orthotopic Glioblastoma.
Zhang J; Han L; Wu H; Zhong Y; Shangguan P; Liu Y; He M; Sun H; Song C; Wang X; Liu Y; Wang J; Zheng L; Shi B; Tang BZ
Adv Sci (Weinh); 2023 May; 10(13):e2206333. PubMed ID: 36869410
[TBL] [Abstract][Full Text] [Related]
4. IRGD-modified erythrocyte membrane biomimetic temozolomide nanodots for the treatment of glioblastoma.
Luo D; Chen Z; Peng Y; Liu C
Nanotechnology; 2024 Mar; 35(24):. PubMed ID: 38408368
[TBL] [Abstract][Full Text] [Related]
5. TfR Aptamer Enhanced Blood-Brain Barrier Penetration of Biomimetic Nanocomplexes for Intracellular Transglutaminase 2 Imaging and Silencing in Glioma.
Su J; Yao Z; Chen Z; Zhou S; Wang Z; Xia H; Liu S; Wu Y
Small; 2022 Oct; 18(40):e2203448. PubMed ID: 35980938
[TBL] [Abstract][Full Text] [Related]
6. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
[TBL] [Abstract][Full Text] [Related]
7. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment.
Wan S; Zhang G; Liu R; Abbas MN; Cui H
Cell Commun Signal; 2023 May; 21(1):115. PubMed ID: 37208730
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain Barrier Permeable and Multi-stimuli Responsive Nanoplatform for Orthotopic Glioma Inhibition by Synergistic Enhanced Chemo-/Chemodynamic/Photothermal/Starvation Therapy.
Cao Y; Jin L; Zhang S; Lv Z; Yin N; Zhang H; Zhang T; Wang Y; Chen Y; Liu X; Zhao G
Eur J Pharm Sci; 2023 Jan; 180():106319. PubMed ID: 36328086
[TBL] [Abstract][Full Text] [Related]
10. Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma.
Zhang D; Tian S; Liu Y; Zheng M; Yang X; Zou Y; Shi B; Luo L
Nat Commun; 2022 Nov; 13(1):6835. PubMed ID: 36369424
[TBL] [Abstract][Full Text] [Related]
11. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
[TBL] [Abstract][Full Text] [Related]
13. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
Wu S; Lu L; Zhou J; Ran D; Wang S; Xu Q; Xu W; Wang J; Liu Y; Xie C; Luo Z; Lu W
J Control Release; 2022 May; 345():685-695. PubMed ID: 35346767
[TBL] [Abstract][Full Text] [Related]
14. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
[TBL] [Abstract][Full Text] [Related]
15. Ultrasmall iron oxide nanoparticles with MRgFUS for enhanced magnetic resonance imaging of orthotopic glioblastoma.
Chen J; Yang R; Yu H; Wu H; Wu N; Wang S; Yin X; Shi X; Wang H
J Mater Chem B; 2024 May; 12(20):4833-4842. PubMed ID: 38647018
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
17. Super-small zwitterionic micelles enable the improvement of blood-brain barrier crossing for efficient orthotopic glioblastoma combinational therapy.
Wang K; Zhao B; Ao Y; Zhu J; Zhao C; Wang W; Zou Y; Huang D; Zhong Y; Chen W; Qian H
J Control Release; 2023 Dec; 364():261-271. PubMed ID: 37839641
[TBL] [Abstract][Full Text] [Related]
18. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
[TBL] [Abstract][Full Text] [Related]
19. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.
Martins C; Araújo M; Malfanti A; Pacheco C; Smith SJ; Ucakar B; Rahman R; Aylott JW; Préat V; Sarmento B
Small; 2023 Jun; 19(22):e2300029. PubMed ID: 36852650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
